Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exatecan mesylate in refractory ovarian, tubal, or peritoneal cancer
NCT00004060Phase 2Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Jul 1999
- Primary completion
- Sep 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of exatecan in ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal cancer (PPC), sponsored by Daiichi Sankyo Co., Ltd.. Started Jul 1999; status: completed.
02
Drugs
exatecan
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT00004060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004060.